129 related articles for article (PubMed ID: 2224438)
1. The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumours.
Mulders PF; Oosterhof GO; Boetes C; de Mulder PH; Theeuwes AG; Debruyne FM
Br J Urol; 1990 Oct; 66(4):425-9. PubMed ID: 2224438
[TBL] [Abstract][Full Text] [Related]
2. Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.
Gerl A; Clemm C; Schmeller N; Dienemann H; Weiss M; Kriegmair M; Löhrs U; Wilmanns W
Br J Cancer; 1994 Nov; 70(5):960-5. PubMed ID: 7524606
[TBL] [Abstract][Full Text] [Related]
3. Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma.
Tait D; Peckham MJ; Hendry WF; Goldstraw P
Br J Cancer; 1984 Nov; 50(5):601-9. PubMed ID: 6093838
[TBL] [Abstract][Full Text] [Related]
4. Testicular tumors: residual retroperitoneal mass surgery after chemotherapy;Is it possible to predict their histology?
Medina-Polo J; Martínez-Silva V; Domínguez-Esteban M; de la Rosa-Kehrmann F; Villacampa-Aubá F; Castellano-Gauna D; Díaz-González R
Arch Esp Urol; 2011 Sep; 64(7):611-9. PubMed ID: 21965259
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery. EORTC Genitourinary Tract Cancer Cooperative Group (EORTC GU Group).
Jansen RL; Sylvester R; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; Jones WG; Keizer J; van Oosterom AT; Meyer S; Vendrik CP
Eur J Cancer; 1991; 27(6):695-8. PubMed ID: 1829907
[TBL] [Abstract][Full Text] [Related]
6. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer tumors of the testis.
Culine S
Eur Urol; 2008 Feb; 53(2):273-4. PubMed ID: 18045772
[No Abstract] [Full Text] [Related]
7. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors of the testis.
Jacqmin D
Eur Urol; 2008 Feb; 53(2):272-3. PubMed ID: 18045771
[No Abstract] [Full Text] [Related]
8. Does necrosis on frozen-section analysis of a mass after chemotherapy justify a limited retroperitoneal resection in patients with advanced testis cancer?
Herr HW
Br J Urol; 1997 Oct; 80(4):653-7. PubMed ID: 9352708
[TBL] [Abstract][Full Text] [Related]
9. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
[TBL] [Abstract][Full Text] [Related]
10. [Bilateral and synchronous testicular teratoma: a case report and literature review].
Matabuena-Tamez P; Canepa-Fernández P; Valencia-García LC; Gutiérrez-Samperio C; Gallegos-Corona MA
Cir Cir; 2015; 83(6):527-31. PubMed ID: 26164135
[TBL] [Abstract][Full Text] [Related]
11. The extent of surgery after chemotherapy for advanced germ cell tumors.
Freiha FS; Shortliffe LD; Rouse RV; Mark JB; Hannigan JF; Aston D; Spaulding JT; Williams RD; Torti FM
J Urol; 1984 Nov; 132(5):915-7. PubMed ID: 6208386
[TBL] [Abstract][Full Text] [Related]
12. Metastatic embryonal cell carcinoma of testis: an apparent 8-year cure.
Dees JE
J Urol; 1973 Jul; 110(1):90-2. PubMed ID: 4713368
[No Abstract] [Full Text] [Related]
13. Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors.
Gelderman WA; Koops HS; Sleijfer DT; Oosterhuis JW; Oldhoff J
Cancer; 1986 Oct; 58(7):1418-21. PubMed ID: 2427186
[TBL] [Abstract][Full Text] [Related]
14. Post-chemotherapy tumor residuals in patients with advanced nonseminomatous testicular cancer. Is it necessary to resect all residual masses?
Qvist HL; Fosså SD; Ous S; Høie J; Stenwig AE; Giercksky KE
J Urol; 1991 Feb; 145(2):300-2; discussion 302-3. PubMed ID: 1988722
[TBL] [Abstract][Full Text] [Related]
15. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
[TBL] [Abstract][Full Text] [Related]
16. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis.
Heidenreich A; Thüer D; Polyakov S
Eur Urol; 2008 Feb; 53(2):260-72. PubMed ID: 18045770
[TBL] [Abstract][Full Text] [Related]
17. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
[TBL] [Abstract][Full Text] [Related]
18. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours.
Hartmann JT; Candelaria M; Kuczyk MA; Schmoll HJ; Bokemeyer C
Eur J Cancer; 1997 May; 33(6):843-7. PubMed ID: 9291803
[TBL] [Abstract][Full Text] [Related]
19. An analysis of surveillance for stage I combined teratoma--seminoma of the testis.
Thomas R; Dearnaley D; Nicholls J; Norman A; Sampson S; Horwich A
Br J Cancer; 1996 Jul; 74(1):59-62. PubMed ID: 8679458
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive surgery in disseminated non-seminomatous germ cell tumours of testis.
Kulkarni RP; Reynolds KW; Newlands ES; Dawson PM; Makey AR; Theodorou NA; Bradley J; Begent RH; Rustin GJ; Bagshawe KD
Br J Surg; 1991 Feb; 78(2):226-9. PubMed ID: 1707715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
